Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination
by 75th World Health AssemblyGuidance for best practices for clinical trials
by The World Health OrganizationHow can community engagement in health research be strengthened for infectious disease outbreaks in Sub-Saharan Africa? A scoping review of the literature.
by Samantha Vanderslott, Manya Van Ryneveld, Mark Marchant, Shelley Lees, Sylvie Kwedi Nolna, Vicki MarshThe “3 Ps” of EmPowerment, Partnership and Protection – Stakeholder Perceptions of Beneficial Outcomes of Engagement in HIV Prevention Trials
by Abigail Wilkinson, Siyabonga Thabete, Jessica Salzwedel, Cathy SlackSystematic review of community engagement approach in research: describing partnership approaches, challenges and benefits
by Getachew Redeae Taffere, Haftom Temesgen Abebe, Zenawi Zerihun, Christian Mallen, Helen P. Price, Afework MulugetaA systematic review of community engagement with health research.
A rapid review of community engagement and informed consent processes for adaptive platform trials and alternative design trials for public health emergencies
by Alun Davies et al.Guides and Tools: LGB Patient and Public involvement and Engagement in Research - a "How to" Guide for Researchers
by LBG Open Innovation in Science CenterThe ‘How to’ Guide for Researchers was co-developed by different stakeholders coordinated by the LBG Open Innovation in Science Center to support the implementation of public and patient involvement (PPIE) in research.
Guide: Essential Principles & Practices for GPP Compliance: Engaging stakeholders in biomedical research during the era of COVID-19
by Mesh Editorial TeamThis tool from AVAC in intended to help guide stakeholder engagement in COVID-19 research. Built from the Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP), it responds to needs expressed by both researchers and advocates.
Guide: WHO R&D Good Participatory Practice for COVID-19 clinical trials: a toolbox
by Mesh Editorial TeamThis toolbox was developed in 2020 for the World Health Organisation COVID-19 Research Roadmap and provides a synthesis of key action points from the WHO GPP-EP guidelines. This “how to” guide gives an overview, tips and resources and will be updated as new resources are completed and approved.
Guide: WHO guidelines on Good Participatory Practice for Trials of Emerging Pathogens (GPP-EP)
by Mesh Editorial Team, Dr Catherine HankinsGPP-EP were prepared in 2016 by the WHO to support prevention and treatment trials of emerging (and re-emerging) pathogens that were likely to cause severe outbreaks. The guidelines address how to engage community stakeholders and promote ethical standards throughout the research process.
Although these Good Participatory Practice (GPP) Guidelines were developed by AVAC and UNAIDS for HIV prevention trials, they are valuable to clinical trials across fields, research areas, geographies and populations.
Guide: TB Alliance Good Participatory Practice Guidelines for TB Drug Trials (GPP-TB)
by Mesh Editorial Team, Critical Path to TB Drug RegimensProviding guiding principles and practice standards for stakeholder engagement as an integral part of TB drug trials. Stakeholder engagement refers to any form of consultation, collaboration, and partnership put in place to enable a dialogue between all parties having a stake in a specific trial.